Skip to main content

Perioral Wrinkles

1
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Galderma
GaldermaTX - Dallas
1 program
1
Poly-L-Lactic AcidPhase 41 trial
Active Trials
NCT07225348Recruiting26Est. Oct 2026
Croma-Pharma
Croma-PharmaAustria - Leobendorf
1 program
Saypha® RichN/A1 trial
Active Trials
NCT07398768Recruiting34Est. Jul 2026

Trial Timeline

Clinical trial activity over time

2025
2026
GaldermaPoly-L-Lactic Acid
Croma-PharmaSaypha® Rich

Clinical Trials (2)

Total enrollment: 60 patients across 2 trials

NCT07225348GaldermaPoly-L-Lactic Acid

Treatment of Perioral Wrinkles Using Topical Poly-L-lactic Acid and Microneedling Device

Start: Nov 2025Est. completion: Oct 202626 patients
Phase 4Recruiting

Prospective, Non-interventional Study Assessing Perioral Rejuvenation Procedure

Start: Feb 2026Est. completion: Jul 202634 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 60 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.